| Grantee's Name | Grantee's Address | Grant Date | Grant Amount | Grant Purpose | Amount Expended By Grantee | Any Diversion By Grantee? | Dates of Reports By Grantee | Date of Verification | Results of Verification |
|---|---|---|---|---|---|---|---|---|---|
|
AMERICAN SOUTH REAL ESTATE FUND |
1281 WESTWOOD BLVD STE 200 LOS ANGELES,CA90024 |
2018-12-21 | 1,889,291 | PRI INVESTMENT: TO INVEST IN REAL ESTATE PROJECTS IN 10 SOUTHERN STATES WHICH WILL CREATE WORKFORCE HOUSING, CONSTRUCTION AND PERMANENT JOBS THAT WILL BENEFIT LOW-INCOME COMMUNITIES AND FURTHERING THE FOUNDATION'S TAX EXEMPT PURPOSE. | 1,889,291 | NO KNOWN DIVERSION OF ANY PORTION OF THE PRI FUNDS. | 4/30/19, 7/26/20, 8/28/20, 11/20/20, 4/30/21, 04/26/23 | THE FOUNDATION HAS NO REASON TO DOUBT THE ACCURACY OR RELIABILITY OF THE REPORT FROM THE GRANTEE. THEREFORE, NO INDEPENDENT VERIFICATION OF THE REPORT WAS MADE. | |
|
VAMOSVENTURES FUND I LP |
745 SOUTH OAKLAND AVENUE PASADENA,CA91106 |
2020-12-18 | 600,000 | VAMOSVENTURES IS A VENTURE CAPITAL PRI INVESTMENT THAT INVESTS IN EARLY-STAGE, TECH-ENABLED COMPANIES LED BY LATINX AND DIVERSE FOUNDERS. VAMOSVENTURES AIMS TO INVEST IN COMPANIES DISMANTLING INEQUITIES ACROSS HEALTHCARE, WEALTH CREATION, FUTURE OF INCOME, AND CLIMATE CHANGE. VAMOSVENTURES BELIEVES HIGH-GROWTH AND SCALABLE TECH SOLUTIONS WILL BE THE CATALYST FOR A MORE EQUITABLE TOMORROW | 600,000 | NO KNOWN DIVERSION OF ANY PORTION OF THE PRI FUNDS. | 05/14/22, 05/12/23 | THE FOUNDATION HAS NO REASON TO DOUBT THE ACCURACY OR RELIABILITY OF THE REPORT FROM THE GRANTEE. THEREFORE, NO INDEPENDENT VERIFICATION OF THE REPORT WAS MADE. | |
|
CANARY |
5 UNION SQUARE WEST 1067 NEW YORK,NY10003 |
2021-01-01 | 250,000 | CANARY IS AN EQUITY PRI THAT IS COMMITTED TO PROVIDING TIMELY FINANCIAL ASSISTANCE AND THE EVOLUTION OF THE SOCIAL SAFETY NET. | 250,000 | NO KNOWN DIVERSION OF ANY PORTION OF THE PRI FUNDS. | 4/27/22, 01/20/23, 8/8/23 | THE FOUNDATION HAS NO REASON TO DOUBT THE ACCURACY OR RELIABILITY OF THE REPORT FROM THE GRANTEE. THEREFORE, NO INDEPENDENT VERIFICATION OF THE REPORT WAS MADE. | |
|
GENBIOPRO |
2215-B RENAISSANCE DRIVE LAS VEGAS,NV89119 |
2022-12-31 | 800,000 | GENBIOPRO IS A DEBT PRI TO FUND CLINICAL TRIALS TO ESTABLISH ADDITIONAL FOOD AND DRUG ADMINISTRATION APPROVED INDICATIONSFOR THE MEDICATION MIFEPRISTONE IN SUPPORT OF THE CREATION OF AN INTEGRATED AND EXPANDED PORTFOLIO OF REPRODUCTIVE HEALTH PRODUCTS. | 800,000 | NO KNOWN DIVERSION OF ANY PORTION OF THE PRI FUNDS. | 9/22/23 | THE FOUNDATION HAS NO REASON TO DOUBT THE ACCURACY OR RELIABILITY OF THE REPORT FROM THE GRANTEE. THEREFORE, NO INDEPENDENT VERIFICATION OF THE REPORT WAS MADE. |